Sec. 19a-900a. Administration of epinephrine to certain children for purpose of emergency first aid.
Sec. 19a-906. Telehealth services.
Sec. 19a-900. Use of epinephrine by staff member of before or after school program, day camp or child care facility. (a) For the purposes of this section:
(1) “Before or after school program” means any educational or recreational program for children administered in any building or on the grounds of any school by a local or regional board of education or other municipal agency, before or after regular school hours, or both, but does not include a program that is licensed by the Department of Public Health;
(2) “Epinephrine” means an automatic prefilled cartridge injector or similar automatic injectable equipment, nasal spray or any other medical equipment approved by the United States Food and Drug Administration that is used to deliver epinephrine in a standard dose for emergency first aid response to allergic reactions;
(3) “Day camp” means any recreational camp program operated by a municipal agency; and
(4) “Child care facility” means any child care center or group child care home, as described in subdivisions (1) and (2) of subsection (a) of section 19a-77, that is excluded from the licensing requirements of sections 19a-77 to 19a-87, inclusive, by subsection (b) of section 19a-77.
(b) Upon the request and with the written authorization of the parent or guardian of a child attending any before or after school program, day camp or child care facility, and pursuant to the written order of (1) a physician licensed to practice medicine, (2) a physician assistant licensed to prescribe in accordance with section 20-12d, or (3) an advanced practice registered nurse licensed to prescribe in accordance with sections 20-94a and 20-94b, the owner or operator of such before or after school program, day camp or child care facility shall approve and provide general supervision to an identified staff member trained to administer epinephrine to such child if the child has a medically diagnosed allergic condition that may require prompt treatment in order to protect the child against serious harm or death. Such staff member shall be trained in the use of epinephrine by a licensed physician, physician assistant, advanced practice registered nurse or registered nurse or shall complete a course in first aid offered by the American Red Cross, the American Heart Association, the National Ski Patrol, the Department of Public Health, any director of health or an organization using guidelines for first aid and published by the American Heart Association and the American Red Cross.
(P.A. 05-144, S. 2; 05-272, S. 35; P.A. 06-196, S. 151; P.A. 15-227, S. 25; P.A. 16-163, S. 36; P.A. 19-105, S. 6; P.A. 25-143, S. 23.)
History: P.A. 05-272 amended Subsec. (a)(1) by redefining “Before or after school program” to include programs administered, rather than offered, by a school board or municipality and by removing private providers from the definition, and amended Subsec. (b) by changing “and” to “or” in provision re training and education of staff members; P.A. 06-196 made a technical change in Subsec. (b), effective June 7, 2006; pursuant to P.A. 15-227, “child day care center” and “group day care home” were changed editorially by the Revisors to “child care center” and “group child care home”, respectively, in Subsec. (a)(4), effective July 1, 2015; P.A. 16-163 replaced “day care facility” with “child care facility” and made a technical change, effective June 9, 2016; P.A. 19-105 amended Subsec. (b) by adding provision re organization using guidelines published by the American Heart Association and American Red Cross and make technical changes, effective July 1, 2019; P.A. 25-143 amended Subsec. (a)(2) by changing the defined term from “cartridge injector” to “epinephrine” and adding reference to nasal spray and other medical equipment and amended Subsec. (b) by replacing references to cartridge injector with epinephrine, effective July 1, 2025.
| (Return to Chapter Table of Contents) |
(Return to List of Chapters) |
(Return to List of Titles) |
Sec. 19a-900a. Administration of epinephrine to certain children for purpose of emergency first aid. Any provider of child care services, as described in section 19a-77, that is licensed by the Office of Early Childhood or is exempt from licensure pursuant to subsection (b) of section 19a-77, and maintains a supply of epinephrine pursuant to section 19a-909, may administer such epinephrine for the purpose of emergency first aid to a child in the care of such provider who experiences an allergic reaction and does not have a prior written authorization of a parent or guardian or a prior written order of a qualified medical professional for the administration of epinephrine, provided the person administering such epinephrine is a person with training, as defined in section 19a-909. The parent or guardian of a child may submit, in writing, to such child's provider of child care services, that epinephrine shall not be administered to such child pursuant to this section.
(P.A. 23-150, S. 3; P.A. 24-93, S. 9; P.A. 25-143, S. 24.)
History: P.A. 23-150 effective July 1, 2023; P.A. 24-93 added “or is exempt from licensure pursuant to subsection (b) of section 19a-77” and made conforming changes, effective July 1, 2024; P.A. 25-143 deleted reference to cartridge injectors, effective July 1, 2025.
| (Return to Chapter Table of Contents) |
(Return to List of Chapters) |
(Return to List of Titles) |
Sec. 19a-903b. Hospital designation of health care providers and technologists to perform oxygen-related patient care activities. Training. Competency testing. Exception. A hospital, as defined in section 19a-490b, may designate any licensed health care provider and any certified ultrasound, nuclear medicine, magnetic resonance imaging, radiologic or polysomnographic technologist to perform the following oxygen-related patient care activities in a hospital: (1) Connecting or disconnecting oxygen supply; (2) transporting a portable oxygen source; (3) connecting, disconnecting or adjusting the mask, tubes and other patient oxygen delivery apparatus; and (4) adjusting the rate or flow of oxygen consistent with a medical order. Such provider or technologist may perform such activities only to the extent permitted by hospital policies and procedures, including bylaws, rules and regulations applicable to the medical staff. A hospital shall document that each person designated to perform oxygen-related patient care activities has been properly trained, either through such person's professional education or through training provided by the hospital. In addition, a hospital shall require that such person satisfy annual competency testing. Nothing in this section shall be construed to prohibit a hospital from designating persons who are authorized to transport a patient with a portable oxygen source. The provisions of this section shall not apply to any type of ventilator, continuous positive airway pressure or bi-level positive airway pressure units or any other noninvasive positive pressure ventilation.
(P.A. 10-117, S. 80; P.A. 11-242, S. 2; P.A. 22-58, S. 63; P.A. 25-97, S. 20.)
History: P.A. 11-242 substituted “technologist” for “technician” and provided that nothing in section prohibits hospital from designating persons who are authorized to transport a patient with a portable oxygen source, effective July 1, 2011; P.A. 22-58 added reference to polysomnographic technologist; P.A. 25-97 added reference to magnetic resonance imaging and radiologic technologists, effective July 1, 2025.
| (Return to Chapter Table of Contents) |
(Return to List of Chapters) |
(Return to List of Titles) |
Sec. 19a-906. Telehealth services. (a) As used in this section:
(1) “Asynchronous” means any transmission to another site for review at a later time that uses a camera or other technology to capture images or data to be recorded.
(2) “Facility fee” has the same meaning as provided in section 19a-508c.
(3) “Health record” means the record of individual, health-related information that may include, but need not be limited to, continuity of care documents, discharge summaries and other information or data relating to a patient's demographics, medical history, medication, allergies, immunizations, laboratory test results, radiology or other diagnostic images, vital signs and statistics.
(4) “Medical history” means information, including, but not limited to, a patient's past illnesses, medications, hospitalizations, family history of illness if known, the name and address of the patient's primary care provider if known and other matters relating to the health condition of the patient at the time of a telehealth interaction.
(5) “Medication-assisted treatment” means the use of medications approved by the federal Food and Drug Administration, in combination with counseling and behavioral therapies, to provide a whole-patient approach to the treatment of substance use disorders.
(6) “Originating site” means a site at which a patient is located at the time health care services are provided to the patient by means of telehealth.
(7) “Peripheral devices” means the instruments a telehealth provider uses to perform a patient exam, including, but not limited to, stethoscope, otoscope, ophthalmoscope, sphygmomanometer, thermometer, tongue depressor and reflex hammer.
(8) “Remote patient monitoring” means the personal health and medical data collection from a patient in one location via electronic communication technologies that is then transmitted to a telehealth provider located at a distant site for the purpose of health care monitoring to assist the effective management of the patient's treatment, care and related support.
(9) “Store and forward transfer” means the asynchronous transmission of a patient's medical information from an originating site to the telehealth provider at a distant site.
(10) “Synchronous” means real-time interactive technology.
(11) “Telehealth” means the mode of delivering health care or other health services via information and communication technologies to facilitate the diagnosis, consultation and treatment, education, care management and self-management of a patient's physical and mental health, and includes (A) interaction between the patient at the originating site and the telehealth provider at a distant site, and (B) synchronous interactions, asynchronous store and forward transfers or remote patient monitoring. “Telehealth” does not include the use of facsimile, texting or electronic mail.
(12) “Telehealth provider” means (A) any health care provider licensed pursuant to title 20 and any pharmacist licensed by the Department of Consumer Protection pursuant to title 20 who is providing health care or other health services through the use of telehealth within such provider's scope of practice and in accordance with the standard of care applicable to the profession, and (B) on or before June 30, 2025, an appropriately licensed, certified or registered physician, naturopath, registered nurse, advanced practice registered nurse, physician assistant, psychologist, marital and family therapist, clinical social worker, master social worker, alcohol and drug counselor, professional counselor, dietitian-nutritionist, nurse-midwife, behavior analyst, music therapist or art therapist, in another state or territory of the United States or the District of Columbia, who (i) provides mental or behavioral health care through the use of telehealth within such person's scope of practice and in accordance with the standard of care applicable to the profession, (ii) maintains professional liability insurance, or other indemnity against liability for professional malpractice, in an amount that is equal to or greater than that required for similarly licensed, certified or registered Connecticut mental or behavioral health care providers, (iii) registers with the Department of Public Health, in a form and manner prescribed by the Commissioner of Public Health, as a provider of mental or behavioral health care in the state through the use of telehealth prior to providing telehealth to a patient in the state, and (iv) submits an application to the Department of Public Health for a license, certificate or registration as a mental or behavioral health care provider pursuant to title 20 not later than sixty days after registering with the department pursuant to clause (iii) of this subparagraph and completes the application process for such license, certificate or registration not later than sixty days after submitting such application.
(b) (1) A telehealth provider shall only provide telehealth services to a patient when the telehealth provider: (A) Is communicating through real-time, interactive, two-way communication technology or store and forward technologies; (B) has access to, or knowledge of, the patient's medical history, as provided by the patient, and the patient's health record, including the name and address of the patient's primary care provider, if any; (C) conforms to the standard of care applicable to the telehealth provider's profession and expected for in-person care as appropriate to the patient's age and presenting condition, except when the standard of care requires the use of diagnostic testing and performance of a physical examination, such testing or examination may be carried out through the use of peripheral devices appropriate to the patient's condition; and (D) provides the patient with the telehealth's provider license number and contact information.
(2) At the time of the telehealth provider's first telehealth interaction with a patient, the telehealth provider shall inform the patient concerning the treatment methods and limitations of treatment using a telehealth platform and, after providing the patient with such information, obtain the patient's consent to provide telehealth services. The telehealth provider shall document such notice and consent in the patient's health record. If a patient later revokes such consent, the telehealth provider shall document the revocation in the patient's health record.
(c) Notwithstanding the provisions of this section or title 20, no telehealth provider shall prescribe any schedule I, II or III controlled substance through the use of telehealth, except a schedule II or III controlled substance used (1) as part of medication-assisted treatment, or (2) for the treatment of persons with psychiatric disabilities or substance use disorders, as defined in section 17a-458, provided such prescription is provided in a manner fully consistent with the Ryan Haight Online Pharmacy Consumer Protection Act, 21 USC 829(e), as amended from time to time. A telehealth provider using telehealth to prescribe a schedule II or III controlled substance pursuant to this subsection shall electronically submit the prescription pursuant to section 21a-249.
(d) Each telehealth provider shall, at the time of the initial telehealth interaction, ask the patient whether the patient consents to the telehealth provider's disclosure of records concerning the telehealth interaction to the patient's primary care provider. If the patient consents to such disclosure, the telehealth provider shall provide records of all telehealth interactions to the patient's primary care provider, in a timely manner, in accordance with the provisions of sections 20-7b to 20-7e, inclusive.
(e) Any consent required under this section shall be obtained from the patient, or the patient's legal guardian, conservator or other authorized representative, as applicable.
(f) The provision of telehealth services and health records maintained and disclosed as part of a telehealth interaction shall comply with the provisions of the Health Insurance Portability and Accountability Act of 1996, P.L. 104-191, as amended from time to time.
(g) Nothing in this section shall prohibit: (1) A health care provider from providing on-call coverage pursuant to an agreement with another health care provider or such health care provider's professional entity or employer; (2) a health care provider from consulting with another health care provider concerning a patient's care; (3) orders of health care providers for hospital outpatients or inpatients; or (4) the use of telehealth for a hospital inpatient, including for the purpose of ordering any medication or treatment for such patient in accordance with Ryan Haight Online Pharmacy Consumer Protection Act, 21 USC 829(e), as amended from time to time. For purposes of this subsection, “health care provider” means a person or entity licensed or certified pursuant to chapter 370, 372, 373, 375 to 376b, inclusive, 377, 378, 379, 380, 381a, 382, 382a, 383 to 383d, inclusive, 383f, 383g, 384b, 384d, 397a, 399 or 400j, or licensed or certified pursuant to chapter 368d or 384d.
(h) No telehealth provider or hospital shall charge a facility fee for telehealth services. Such prohibition shall apply to hospital telehealth services whether provided on campus or otherwise. For purposes of this subsection, “hospital” has the same meaning as provided in section 19a-490 and “campus” has the same meaning as provided in section 19a-508c.
(i) (1) No telehealth provider shall provide health care or health services to a patient through telehealth unless the telehealth provider (A) has determined whether the patient has health coverage for such health care or health services, and, if the patient has such health coverage, whether the patient elects to either use such health coverage to pay for such health care or health services, in whole or in part, or pay the telehealth provider directly for such health care or health services without using such coverage, and (B) prior to providing such health care or health services to any patient who elects to pay the telehealth provider in part using such coverage or directly without using such coverage, discloses the cost of such health care or health services to the patient.
(2) Notwithstanding any provision of the general statutes, a telehealth provider who agrees to provide health care or health services to a patient through telehealth shall accept as full payment for such health care or health services:
(A) An amount that is equal to the amount that Medicare reimburses for such health care or health services if the telehealth provider determines that the patient does not have health coverage for such health care or health services;
(B) The amount that the patient's health coverage reimburses and any coinsurance, copayment, deductible or other out-of-pocket expense imposed by the patient's health coverage for such health care or health services if the telehealth provider determines that the patient has health coverage for such health care or health services, unless the patient has explicitly elected to pay the provider directly without using such coverage pursuant to subparagraph (A) of subdivision (1) of this subsection, in which case the patient and provider may mutually agree to a different amount; or
(C) An amount mutually agreed to by the patient and telehealth provider.
(3) If a telehealth provider determines that a patient is unable to pay for any health care or health services described in subdivisions (1) and (2) of this subsection, the provider shall offer to the patient financial assistance if such provider is required to offer to the patient such financial assistance under any applicable state or federal law.
(4) Nothing in this subsection shall be construed to prohibit a patient from paying a telehealth provider directly for health care or health services without seeking coverage from a health carrier for such health care or health services.
(j) Subject to compliance with all applicable federal requirements, state licensing standards, state telehealth laws or any regulation adopted thereunder, a telehealth provider may provide telehealth services pursuant to the provisions of this section from any location to a patient in any location.
(k) Any Connecticut entity, institution or health care provider, that engages or contracts with a telehealth provider who is licensed, certified or registered in another state or territory of the United States or the District of Columbia to provide health care or other health services, but who is not licensed, certified or registered by the Department of Public Health to provide such care or services, shall verify that the telehealth provider has registered with the Department of Public Health pursuant to subparagraph (B)(iii) of subdivision (12) of subsection (a) of this section. The department shall (1) verify the credentials of such telehealth provider in the state in which such provider is licensed, certified or registered, (2) ensure that such telehealth provider is in good standing in such state, and (3) confirm that such telehealth provider maintains professional liability insurance or other indemnity against liability for professional malpractice in an amount that is equal to or greater than that required for similarly licensed, certified or registered health care or other services health provider in the state.
(l) The Commissioner of Public Health shall issue a decision on each application for a license, certificate or registration made by a health care provider pursuant to subparagraph (B)(iv) of subdivision (12) of subsection (a) of this section not later than forty-five days after the completion of the application process for such provider. Notwithstanding any provision of this section, a health care provider who is not licensed, certified or registered as a health care provider by the Department of Public Health pursuant to title 20 shall not provide mental or behavioral health care through telehealth in the state if such provider is on the list of excluded individuals or entities posted in the federal online database maintained by the United States Department of Health and Human Services Office of Inspector General. The commissioner may prohibit a health care provider who is not licensed, certified or registered as a health care provider by the Department of Public Health pursuant to title 20 from registering with the department pursuant to subparagraph (B)(iii) of subdivision (12) of subsection (a) of this section or suspend or revoke a provider's registration made pursuant to said subparagraph, if such provider does not meet any of the requirements set forth in this section or act in accordance with the provisions of subdivision (6) of subsection (a) of section 19a-14.
(P.A. 15-88, S. 1; P.A. 16-25, S. 1, 2; P.A. 18-148, S. 1; P.A. 19-118, S. 67; P.A. 22-81, S. 30, 31; P.A. 24-110, S. 1; P.A. 25-97, S. 36, 37; 25-168, S. 116.)
History: P.A. 16-25 amended Subsec. (a)(11) by adding references to speech and language pathologist, respiratory care practitioner and audiologist, and amended Subsec. (f) by adding references to chapters 376 to 376b, 380, 381a, 383 to 383c, 384b, 397a and 399; P.A. 18-148 amended Subsec. (a) by adding new Subdiv. (2) re definition of “facility fee”, redesignating existing Subdiv. (2) re definition of “health record” as Subdiv. (3), deleting former Subdiv. (3) re definition of “facility fee”, adding new Subdiv. (5) re definition of “medication-assisted treatment”, redesignating existing Subdivs. (5) to (11) as Subdivs. (6) to (12), and amending redesignated Subdiv. (12) by adding references to registered nurse and pharmacist, amended Subsec. (b)(2) by adding provision re patient revoking consent, amended Subsec. (c) by adding provision re exception for schedule II or III controlled substance other than opioid drug, and amended Subsec. (d) by replacing “each telehealth interaction” with “the initial telehealth interaction”, added new Subsec. (e) re consent required under section, redesignated existing Subsecs. (e) to (g) as Subsecs. (f) to (h), and amended redesignated Subsec. (g) by adding Subdiv. (4) re use of telehealth for a hospital inpatient, and adding reference to Ch. 400j, and made technical changes, effective July 1, 2018; P.A. 19-118 amended Subsec. (a)(12) by adding reference to paramedic and made technical changes, effective July 1, 2019; P.A. 22-81 amended Subsec. (a)(12) by redefining “telehealth provider” and amended Subsec. (h) by adding provisions re prohibition on hospitals charging facility fees and defining “hospital” and “campus”, effective May 24, 2022; P.A. 24-110 amended Subsec. (a) by redefining “telehealth” in Subdiv. (11) and “telehealth provider” in Subdiv. (12), Subsec. (g) by redefining “health care provider”, and added Subsec. (i) prohibiting provision of telehealth unless provider has determined whether patient has health coverage and requiring disclosure of cost of services to any patient who elects to pay provider directly in whole or in part and requirements for acceptance of payment by a provider, offering of financial assistance and patients paying a provider directly, added Subsec. (j) re provision of services from any location to a patient in any location, added Subsec. (k) re verification of registration of an out-of-state provider with the department, and added Subsec. (l) re issuance of a decision on an application made by an out-of-state telehealth provider, effective June 4, 2024; P.A. 25-97 made a technical change in Subsecs. (a) and (f); P.A. 25-168 amended Subsec. (c) by deleting “other than an opioid drug, as defined in section 20-14o”, adding Subdivs. (1) and (2) re substances used as part of medication-assisted treatment or for the treatment of persons with psychiatric disabilities or substance use disorders and making a conforming change, effective June 30, 2025.
| (Return to Chapter Table of Contents) |
(Return to List of Chapters) |
(Return to List of Titles) |
Sec. 19a-909. Access to and maintenance and administration of epinephrine by authorized entities. Limitation on liability. (a) As used in this section:
(1) “Epinephrine” means an automatic prefilled cartridge injector or similar automatic injectable equipment, nasal spray or any other medical equipment approved by the United States Food and Drug Administration that is used to deliver epinephrine in a standard dose for an emergency first aid response to allergic reactions;
(2) “Person with training” means a person who (A) (i) has completed a course in first aid that includes training in recognizing the signs and symptoms of anaphylaxis, administering epinephrine and following emergency protocol, approved by a prescribing practitioner pursuant to a medical protocol established in accordance with subsection (b) of this section, which course may be offered by the American Red Cross, the American Heart Association, the National Ski Patrol, the Department of Public Health or any director of health, and (ii) is certified by said organizations, department or director of health offering the course, or (B) who has received training in the recognition of the signs and symptoms of anaphylaxis, the use of epinephrine and emergency protocol by a licensed physician, physician assistant, advanced practice registered nurse or emergency medical services personnel;
(3) “Documentation evidencing training” includes a certificate issued by the American Red Cross, the American Heart Association, the National Ski Patrol, the Department of Public Health or any director of health or a written statement of acknowledgment of training signed by a licensed physician, physician assistant, advanced practice registered nurse or emergency medical services personnel; and
(4) “Authorized entity” means any for-profit or nonprofit entity or organization that employs at least one person with training. “Authorized entity” does not include the state or any political subdivision thereof authorized to purchase epinephrine pursuant to subsection (h) of section 21a-70, a local or regional board of education required to maintain epinephrine pursuant to subdivision (2) of subsection (d) of section 10-212a or a licensed or a certified ambulance service required to be equipped with epinephrine cartridge injectors pursuant to subsection (b) of section 19a-197a.
(b) An authorized entity and a prescribing practitioner, as defined in section 20-14c, who is authorized to prescribe epinephrine, may establish a medical protocol regarding the administration of epinephrine by a person with training who is employed by or an agent of an authorized entity for the purpose of rendering emergency care in accordance with subsection (d) of this section. Such medical protocol shall include, but need not be limited to, (1) any training required, in addition to the training required under subdivision (2) of subsection (a) of this section, for an employee or agent of an authorized entity to be designated as a person with training, (2) the records to be maintained in accordance with this subsection and subsections (c) and (e) of this section, (3) the proper storage and maintenance of epinephrine, and (4) the procedure for handling emergency medical situations involving anaphylactic allergic reactions at the authorized entity's place of business. Any such medical protocol shall be deemed established for a legitimate medical purpose in the usual course of the prescribing practitioner's professional practice. An authorized entity shall maintain a copy of such medical protocol established under this section at the place of business to which it applies and, not less than annually, review such medical protocol with the designated persons with training and the prescribing practitioner.
(c) An authorized entity that has established a medical protocol with a prescribing practitioner pursuant to subsection (b) of this section may acquire and maintain a supply of epinephrine from a wholesaler, as defined in section 21a-70. The epinephrine shall be stored in a location readily accessible in an emergency, in accordance with the instructions for use included with such epinephrine and the established medical protocol. An authorized entity shall designate a person or persons with training who are employees or agents of the authorized entity to be responsible for the storage, maintenance and control of the epinephrine. An authorized entity shall maintain documentation (1) of all epinephrine acquired by such authorized entity, and (2) evidencing the training acquired by each such designated person with training.
(d) A person with training who is an employee or agent of an authorized entity that acquires and maintains a supply of epinephrine pursuant to subsection (c) of this section may, in accordance with the established medical protocol, (1) provide epinephrine to an individual or to the parent, guardian or caregiver of an individual, whom the person with training believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for epinephrine or a prior medical diagnosis of an allergic condition, for the purpose of immediate administration of such epinephrine by such individual, parent, guardian or caregiver, or (2) administer epinephrine to an individual whom the person with training believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for epinephrine or a prior medical diagnosis of an allergic condition. The person with training or any other employee or agent of the authorized entity shall promptly notify a local emergency medical services organization after any administration of epinephrine acquired and maintained by the authorized entity.
(e) Each authorized entity shall report to the prescribing practitioner with whom it has established a medical protocol any incident that involves the administration of epinephrine acquired and maintained by the authorized entity under this section not later than thirty days after the date of such incident and shall maintain a record of such incident.
(f) (1) A prescribing practitioner who is authorized to prescribe epinephrine may establish a medical protocol with an authorized entity in accordance with this section without being liable for damages in a civil action or subject to criminal prosecution for establishing such medical protocol or for any subsequent use of epinephrine acquired and maintained by the authorized entity under this section. A prescribing practitioner who has established a medical protocol with an authorized entity in accordance with the provisions of this section shall be deemed not to have violated the standard of care for such licensed health care provider.
(2) A person with training or an authorized entity that employs or has an agent who is a person with training who provides or administers epinephrine to an individual whom the person with training believes in good faith is experiencing anaphylaxis in accordance with the provisions of this section shall not be liable to such individual for civil damages or subject to criminal prosecution for any personal injuries that result from acts or omissions by such person with training in using epinephrine, which may constitute ordinary negligence. The immunity provided in this subsection shall not apply to wilful or wanton misconduct or acts or omissions constituting gross negligence.
(g) The Commissioner of Consumer Protection or Public Health may adopt regulations, in accordance with chapter 54, to implement the provisions of this section.
(P.A. 19-19, S. 1; 19-118, S. 63; P.A. 25-143, S. 25.)
History: P.A. 19-19 effective June 13, 2019 (Revisor's note: In Subsec. (b) “subdivision (2) of section 1 of this act” was changed to “subdivision (2) of subsection (a) of this section” for accuracy); P.A. 19-118 amended Subsec. (a) by adding “and sections 2 and 3 of this act”, effective July 9, 2019 (Revisor's note: In codifying this section, an incorrect reference to “sections 2 and 3 of this act” was deemed by the Revisors to be a reference to Secs. 21a-70 and 52-557v, which are Secs. 2 and 3 of P.A. 19-19); P.A. 25-143 deleted applicability of definitions to Secs. 21a-70 and 52-557v, deleted references to “cartridge injector”, amended Subsec. (a)(1) by changing defined term from “epinephrine cartridge injector” to “epinephrine” and adding reference to nasal spray and other medical equipment and made a technical change in Subsec. (g), effective July 1, 2025.
| (Return to Chapter Table of Contents) |
(Return to List of Chapters) |
(Return to List of Titles) |
Sec. 19a-919. Consent by a minor for services, examination or treatment related to pregnancy and pregnancy prevention. Confidentiality and liability for costs. (a) As used in this section:
(1) “Health care provider” means any person, corporation, limited liability company, facility or institution operated, owned or licensed by the state to provide health care or other professional services, or an officer, employee or agent thereof acting in the course and scope of his or her employment;
(2) “Minor child” means a person who is under eighteen years of age;
(3) “Physician” means a physician licensed pursuant to chapter 370; and
(4) “Services, examination or treatment related to pregnancy and pregnancy prevention” (A) includes, but is not limited to, contraceptive counseling and services, prenatal care and appropriate care and pain management during labor and delivery, including, but not limited to, epidural administration, but (B) does not include sterilization.
(b) Any minor child may give consent for services, examination or treatment related to pregnancy and pregnancy prevention without the consent or notification of the minor child's parent or guardian.
(c) No physician or other health care provider shall divulge any information concerning the provision to a minor child of such services, examination or treatment, or any consultation for such services, examination or treatment, including, but not limited to, by sending a bill for such services, examination or treatment, to the minor child's parent or guardian without the minor child's express consent.
(d) Nothing in this section shall be construed to affect the obligation, if any, of a physician or other health care provider to make a report to the Department of Public Health or Children and Families, or to make any other report or disclosure that may be required pursuant to state law.
(e) Any parent or guardian who was not informed of the provision of such services, examination or treatment to such parent's or guardian's minor child, shall not be liable for the costs of such services, examination or treatment.
(P.A. 25-28, S. 1.)
History: P.A. 25-28 effective June 9, 2025.
| (Return to Chapter Table of Contents) |
(Return to List of Chapters) |
(Return to List of Titles) |
Sec. 19a-920. Provision of bank account information, credit card or debit card number or any other form of electronic payment as prerequisite to seeing patient or providing health care service to a patient. Prohibited. (a) No health system, as defined in section 19a-508c, or health care provider shall require a patient to provide bank account information, a credit card number, a debit card number or any other form of electronic payment to be kept on file with the health system or health care provider as a prerequisite to seeing the patient for an office visit or providing any health care service to the patient.
(b) A violation of subsection (a) of this section shall be considered an unfair trade practice pursuant to section 42-110b.
(c) Nothing in this section shall be construed to (1) affect a patient's obligation to pay for health care services, or (2) prohibit a health care provider from requesting, collecting or storing bank, credit or debit card or other payment-related information if the patient agrees to provide such information.
(P.A. 25-97, S. 4.)
| (Return to Chapter Table of Contents) |
(Return to List of Chapters) |
(Return to List of Titles) |